Elucid today announced that, effective January 1, 2026, its Plaque-IQ(TM) coronary plaque analysis has received a new Category I Current Procedural Terminology (CPT(R)) designation, alongside ...
CHICAGO, Jan. 14, 2026 (GLOBE NEWSWIRE) -- Omniscient ("o8t (R)"), a global pioneer in the use of AI to decode the human brain, today announced the issuance of a new Category III Current Procedural ...
CHICAGO, Jan. 14, 2026 (GLOBE NEWSWIRE) -- Omniscient (“o8t®”), a global pioneer in the use of AI to decode the human brain, ...
The probe began after STAT and others reported on UnitedHealth's strategies to boost profits in Medicare Advantage.
The American College of Cardiology found uneven gains and sobering declines in heart health. "You can't treat your way out of ...
Updated guidance on vascular cognitive impairment emphasizes executive function and processing speed, endorses brief, ...
A phase 3 trial shows no impact of the anticoagulant rivaroxaban on the risk of cognitive decline in individuals with atrial fibrillation and low thromboembolic risk — highlighting the need for a ...
The US Department of Veterans Affairs and DoD published updated recommendations for the primary care management of chronic kidney disease.
W H O’s Global HEARTS is the largest worldwide effort to improve hypertension control through standardised care. HEARTS in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback